The activist's full exit removes the most powerful catalyst for a sale or strategic change at PCRX. Without DOMA's pressure, the stock is likely to re-rate lower as the takeout premium dissipates. Watch for potential new activist entry or a significant sell-off as the market reprices the stock without the activist overhang.
Price Chart
Executive Summary
DOMA Perpetual Capital Management and its affiliates have fully exited their stake in Pacira BioSciences, selling all 2,936,794 shares on October 8-13, 2026, at ~$36.29-$36.34 per share. The filing states the group ceased to be a beneficial owner of more than 5% as of October 8, 2026, effectively abandoning their activist campaign and proxy fight for board seats and a sale process.
Key Financial Metrics
Key Facts
- DOMA Perpetual and affiliates sold all 2,936,794 shares of PCRX on October 8-13, 2026, at ~$36.29-$36.34 per share.
- The group ceased to be a beneficial owner of more than 5% of PCRX as of October 8, 2026.
- This follows the prior March 12, 2026, activist filing where DOMA nominated three directors and demanded CEO replacement and a formal sale process.
- The complete exit signals the activist has abandoned its proxy fight and sale campaign, removing the primary catalyst for a potential takeout premium.
Financial Impact
Total proceeds from the sale of 2,936,794 shares at ~$36.29-$36.34 per share is approximately $106.5 million.
Risk Factors
- Loss of activist catalyst may lead to significant downside as the takeout premium evaporates.
- PCRX's fundamentals remain challenged (missed earnings, lowered guidance, stock down 56% over 10 years per prior filing).
- No new activist or strategic buyer has emerged to replace DOMA's pressure.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001104659-26-115589 |
| Document: tm2627486d1_ex99-2.htm | 0001104659-26-115589 |
| Document: 0001104659-26-115589-index-headers.html | 0001104659-26-115589 |
| Document: 0001104659-26-115589-index.html | 0001104659-26-115589 |
| Document: 0001104659-26-115589.txt | 0001104659-26-115589 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | SC 13D/A | $36.40 | awaiting T+20 | — | $36.38 (+0.05%) |
Oct 8, 2026 18d ago | SC TO-C | $36.31 | awaiting T+20 | — | $36.38 (+0.19%) |
Oct 8, 2026 18d ago | 144 | $36.39 | awaiting T+20 | — | $36.38 (−0.03%) |
Oct 8, 2026 18d ago | 8-K | $36.39 | awaiting T+20 | — | $36.38 (−0.03%) |
Oct 8, 2026 18d ago | SC TO-C | $36.39 | awaiting T+20 | — | $36.38 (−0.03%) |
Aug 6, 2026 11w ago | Press Release | $25.58 $26.60 | ▲ +3.99% | ▲ +3.39% | $36.38 (+42.22%) |
Jul 22, 2026 13w ago | Press Release | $25.59 $24.36 | ▼ −4.81% | ▼ −7.70% | $36.38 (+42.16%) |
Jun 30, 2026 16w ago | 8-K | $25.37 $26.47 | ▲ +4.34% | ▲ +5.36% | $36.38 (+43.40%) |
Jun 12, 2026 19w ago | Insider Cluster | $22.74 $25.54 | ▲ +12.31% | ▲ +13.06% | $36.38 (+59.98%) |
Jun 4, 2026 20w ago | DEFA14A | $22.75 $25.59 | ▲ +12.48% | ▲ +10.62% | $36.38 (+59.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers